Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| KPCA | P17252 | Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) | Cancer-related genesEnzymesFDA approved drug targets | Human immunodeficiency virus diseaseMuscular atrophyNephritic syndrome | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.40 | |||
| MRC1 | P22897 | Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) | CD markersFDA approved drug targetsPlasma proteins | 1 | COVID-19Type 2 diabetes mellitus | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 5 | 0.40 | ||
| MSLN | Q13421 | Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form] | Cancer-related genesDisease related genesPlasma proteins | Breast cancerCervical cancerEndometrial cancer | Adhesion and uptake mediationClinical-translation mediationMetabolism mediation | 5 | 0.40 | |||
| MTPN | P58546 | Myotrophin (Protein V-1) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationImmune mediationMetabolism mediation | 5 | 0.40 | ||||
| P3C2G | O75747 | Phosphatidylinositol 3-kinase C2 domain-containing subunit gamma (PI3K-C2-gamma) (PtdIns-3-kinase C2 subunit gamma) (EC 2.7.1.137) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-gamma) | Metabolism mediationReceptor-signaling mediation | 5 | 0.40 | |||||
| PAR6A | Q9NPB6 | Partitioning defective 6 homolog alpha (PAR-6) (PAR-6 alpha) (PAR-6A) (PAR6C) (Tax interaction protein 40) (TIP-40) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationReceptor-signaling mediation | 5 | 0.40 | ||||
| PCDG6 | Q9Y5G7 | Protocadherin gamma-A6 (PCDH-gamma-A6) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 5 | 0.40 | |||
| PCDG8 | Q9Y5G5 | Protocadherin gamma-A8 (PCDH-gamma-A8) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 5 | 0.40 | |||
| PI42A | P48426 | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-Phosphate 4-Kinase) (PI5P4Kalpha) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha) | EnzymesMetabolic proteinsPlasma proteins | Fusion and delivery mediationImmune mediationMetabolism mediation | 5 | 0.40 | ||||
| PK3CG | P48736 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.137) (EC 2.7.1.153) (EC 2.7.1.154) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K) | Cancer-related genesDisease related genesEnzymes | COVID-19Follicular lymphomaAdrenal cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 5 | 0.40 |